Literature DB >> 32039912

Can the light of immunometabolism cut through "brain fog"?

Mady Hornig.   

Abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a highly debilitating disease with heterogeneous constitutional and neurological complaints. Infection-like symptoms often herald disease onset, but no pathogen or immune defect has been conclusively linked. In this issue of the JCI, Mandarano et al. illuminate bioenergetic derangements of ME/CFS T cell subsets. CD4+ and CD8+ T cells had impaired resting glycolysis. CD8+ cells additionally showed activation-related metabolic remodeling deficits and decreased mitochondrial membrane potential; a subset had increased resting mitochondrial mass. Immune senescence and exhaustion paradigms offer only partial explanations. Hence, unique mechanisms of disrupted immunometabolism may underlie the complex neuroimmune dysfunction of ME/CFS.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32039912      PMCID: PMC7269580          DOI: 10.1172/JCI134985

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

Review 1.  Fueling immunity: insights into metabolism and lymphocyte function.

Authors:  Erika L Pearce; Maya C Poffenberger; Chih-Hao Chang; Russell G Jones
Journal:  Science       Date:  2013-10-11       Impact factor: 47.728

2.  Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.

Authors:  Øystein Fluge; Olav Mella; Ove Bruland; Kristin Risa; Sissel E Dyrstad; Kine Alme; Ingrid G Rekeland; Dipak Sapkota; Gro V Røsland; Alexander Fosså; Irini Ktoridou-Valen; Sigrid Lunde; Kari Sørland; Katarina Lien; Ingrid Herder; Hanne Thürmer; Merete E Gotaas; Katarzyna A Baranowska; Louis Mlj Bohnen; Christoph Schäfer; Adrian McCann; Kristian Sommerfelt; Lars Helgeland; Per M Ueland; Olav Dahl; Karl J Tronstad
Journal:  JCI Insight       Date:  2016-12-22

Review 3.  Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.

Authors:  Elizabeth Haney; M E Beth Smith; Marian McDonagh; Miranda Pappas; Monica Daeges; Ngoc Wasson; Heidi D Nelson
Journal:  Ann Intern Med       Date:  2015-06-16       Impact factor: 25.391

Review 4.  Symptoms and signs of chronic fatigue syndrome.

Authors:  A L Komaroff; D Buchwald
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

5.  Epigenomics of human CD8 T cell differentiation and aging.

Authors:  David M Moskowitz; David W Zhang; Bin Hu; Sabine Le Saux; Rolando E Yanes; Zhongde Ye; Jason D Buenrostro; Cornelia M Weyand; William J Greenleaf; Jörg J Goronzy
Journal:  Sci Immunol       Date:  2017-02-17

6.  Metabolic features of chronic fatigue syndrome.

Authors:  Robert K Naviaux; Jane C Naviaux; Kefeng Li; A Taylor Bright; William A Alaynick; Lin Wang; Asha Baxter; Neil Nathan; Wayne Anderson; Eric Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

7.  Mitochondrial mass governs the extent of human T cell senescence.

Authors:  Lauren A Callender; Elizabeth C Carroll; Emilia A Bober; Arne N Akbar; Egle Solito; Sian M Henson
Journal:  Aging Cell       Date:  2019-12-02       Impact factor: 9.304

8.  Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations.

Authors:  Alexandra H Mandarano; Jessica Maya; Ludovic Giloteaux; Daniel L Peterson; Marco Maynard; C Gunnar Gottschalk; Maureen R Hanson
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

9.  Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.

Authors:  Marta Curriu; Jorge Carrillo; Marta Massanella; Josepa Rigau; José Alegre; Jordi Puig; Ana M Garcia-Quintana; Jesus Castro-Marrero; Eugènia Negredo; Bonaventura Clotet; Cecilia Cabrera; Julià Blanco
Journal:  J Transl Med       Date:  2013-03-20       Impact factor: 5.531

10.  Association of chronic fatigue syndrome with premature telomere attrition.

Authors:  Mangalathu S Rajeevan; Janna Murray; Lisa Oakley; Jin-Mann S Lin; Elizabeth R Unger
Journal:  J Transl Med       Date:  2018-02-27       Impact factor: 5.531

View more
  4 in total

Review 1.  Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review.

Authors:  Stanley Du Preez; Helene Cabanas; Donald Staines; Sonya Marshall-Gradisnik
Journal:  Int J Environ Res Public Health       Date:  2021-10-12       Impact factor: 3.390

Review 2.  Molecular Hydrogen as a Medical Gas for the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Possible Efficacy Based on a Literature Review.

Authors:  Shin-Ichi Hirano; Yusuke Ichikawa; Bunpei Sato; Yoshiyasu Takefuji; Fumitake Satoh
Journal:  Front Neurol       Date:  2022-04-11       Impact factor: 4.086

3.  Phenotypic characteristics of peripheral immune cells of Myalgic encephalomyelitis/chronic fatigue syndrome via transmission electron microscopy: A pilot study.

Authors:  Fereshteh Jahanbani; Rajan D Maynard; Justin Cyril Sing; Shaghayegh Jahanbani; John J Perrino; Damek V Spacek; Ronald W Davis; Michael P Snyder
Journal:  PLoS One       Date:  2022-08-09       Impact factor: 3.752

4.  Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population.

Authors:  Toshimori Kitami; Sanae Fukuda; Tamotsu Kato; Kouzi Yamaguti; Yasuhito Nakatomi; Emi Yamano; Yosky Kataoka; Kei Mizuno; Yuuri Tsuboi; Yasushi Kogo; Harukazu Suzuki; Masayoshi Itoh; Masaki Suimye Morioka; Hideya Kawaji; Haruhiko Koseki; Jun Kikuchi; Yoshihide Hayashizaki; Hiroshi Ohno; Hirohiko Kuratsune; Yasuyoshi Watanabe
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.